Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Non-voltage-dependent calcium channels" is imprecise and not recognized as a distinct target in contemporary molecular pharmacology. Most calcium channels studied are either voltage-gated (CaV family, such as L-, N-, T-type channels[3][5]), or ligand-gated (such as NMDA receptors, P2X receptors, TRP channels), each with distinct structure, pharmacology, and therapeutic implications. "Non-voltage-dependent calcium channels" may be used colloquially to refer to ligand-gated or store-operated calcium channels, but these represent multiple, discrete protein families with their own standard nomenclature and biology. No approved drugs, biomarkers, or standardized mechanistic information exist for the ambiguous group "non-voltage-dependent calcium channels." Care should be taken to properly identify and specify the precise calcium-permeable channel of interest using accepted nomenclature[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-voltage-dependent calcium channels.